Stage IV Mycosis Fungoides/Sezary Syndrome Completed Phase 2 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0028720 (Stage IV Mycosis Fungoides/Sezary Syndrome)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00049504Fludarabine Phosphate, Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil, Total-Body Irradiation, and Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerTreatment